Re: Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
- PMID: 32603207
- DOI: 10.1097/JU.0000000000001175.01
Re: Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
Comment on
-
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.Clin Cancer Res. 2018 Jul 1;24(13):3069-3078. doi: 10.1158/1078-0432.CCR-17-2687. Epub 2018 Mar 7. Clin Cancer Res. 2018. PMID: 29514839
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
